🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

473 results for “Teva Pharma GmbH” Clear

  1. Gabitril

    Teva Pharma GmbH

    Anxiety Disorder

    phase 3 small molecule completed

    1 trial

  2. Gabitril

    Teva Pharma GmbH

    Anxiety Disorders

    phase 3 small molecule completed

    1 trial

  3. Gabitril

    Teva Pharma GmbH

    Generalized Anxiety Disorder

    phase 3 small molecule completed

    2 trials

  4. Generic Budesonide/Formoterol Fumarate Dihydrate

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    1 trial

  5. Generic Estradiol Vaginal Cream USP, 0.01%

    Teva Pharma GmbH

    Atrophic Vaginitis

    phase 3 small molecule completed

    1 trial

  6. Generic Ivermectin Lotion 0.5%

    Teva Pharma GmbH

    Head Lice

    phase 3 small molecule completed

    1 trial

  7. Glatiramer Acetate

    Teva Pharma GmbH

    Optic Neuritis

    phase 3 small molecule completed

    1 trial

  8. Glatiramer Acetate (DB)

    Teva Pharma GmbH

    Multiple Sclerosis

    phase 3 small molecule completed

    1 trial

  9. Glatiramer Acetate (GA) 40 mg

    Teva Pharma GmbH

    Relapsing Remitting Multiple Sclerosis

    phase 3 small molecule completed

    1 trial

  10. Glatiramer Acetate 20 mg/0.5 mL

    Teva Pharma GmbH

    Multiple Sclerosis

    phase 3 small molecule completed

    1 trial

  11. Glatiramer acetate (GA)

    Teva Pharma GmbH

    Relapsing Remitting Multiple Sclerosis

    phase 3 small molecule completed

    1 trial

  12. Hydrocodone ER

    Teva Pharma GmbH

    Low Back Pain

    phase 3 small molecule completed

    2 trials

  13. Hydrocodone ER

    Teva Pharma GmbH

    Chronic Pain

    phase 3 small molecule completed

    2 trials

  14. Imiquimod Cream, 3.75%

    Teva Pharma GmbH

    Actinic Keratosis

    phase 3 small molecule completed

    1 trial

  15. LI

    Teva Pharma GmbH

    Squamous Cell Carcinoma of the Oral Cavity

    phase 3 mab completed

    1 trial

  16. Laquinimod

    Teva Pharma GmbH

    Relapsing Multiple Sclerosis

    phase 3 small molecule terminated

    2 trials

  17. Laquinimod

    Teva Pharma GmbH

    Multiple Sclerosis

    phase 3 small molecule completed

    3 trials

  18. Laquinimod

    Teva Pharma GmbH

    Relapsing Remitting Multiple Sclerosis

    phase 3 small molecule terminated

    2 trials

  19. Levonorgestrel/EE 0.15/0.03 mg and EE 0.01 mg tablets

    Teva Pharma GmbH

    Contraception

    phase 3 small molecule completed

    1 trial

  20. Modafinil

    Teva Pharma GmbH

    Narcolepsy

    phase 3 small molecule completed

    3 trials

  21. Modafinil

    Teva Pharma GmbH

    ADHD

    phase 3 small molecule completed

    1 trial

  22. Modafinil

    Teva Pharma GmbH

    Attention Deficit/Hyperactivity Disorder

    phase 3 small molecule completed

    3 trials

  23. Modafinil

    Teva Pharma GmbH

    Sleep Apnea, Obstructive

    phase 3 small molecule completed

    1 trial

  24. Myocet

    Teva Pharma GmbH

    Early Primary Breast Cancer

    phase 3 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources